Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥107.21 Million ≈ $15.69 Million USD) by net assets (CN¥3.13 Billion ≈ $458.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Haoyuan Chemexpress Co. Ltd. A market cap and net worth for the company's overall valuation and market capitalisation.
Shanghai Haoyuan Chemexpress Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A ranked by their cash flow conversion efficiency. Explore 688131 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rev Group Inc
NYSE:REVG
|
0.185x |
|
North Industries Group Red Arrow Co Ltd
SHE:000519
|
0.039x |
|
Downer Edi Ltd
AU:DOW
|
0.105x |
|
Betta Pharmaceuticals Co Ltd
SHE:300558
|
0.033x |
|
BankUnited Inc
NYSE:BKU
|
0.043x |
|
Hang Zhou Iron & Steel Co Ltd
SHG:600126
|
0.124x |
|
Shenzhen Everbest Machinery Indus
SHE:002980
|
0.001x |
|
CRRC Corporation Limited
F:C2L
|
-0.034x |
Annual Cash Flow Conversion Efficiency for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025. View Shanghai Haoyuan Chemexpress Co. Ltd. A stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥9.43 Billion ≈ $1.38 Billion |
CN¥317.75 Million ≈ $46.50 Million |
0.034x | -74.37% |
| 2024-12-31 | CN¥2.90 Billion ≈ $424.98 Million |
CN¥381.96 Million ≈ $55.89 Million |
0.132x | +633.61% |
| 2023-12-31 | CN¥2.53 Billion ≈ $369.67 Million |
CN¥-62.27 Million ≈ $-9.11 Million |
-0.025x | +76.07% |
| 2022-12-31 | CN¥2.33 Billion ≈ $341.24 Million |
CN¥-240.23 Million ≈ $-35.15 Million |
-0.103x | -427.11% |
| 2021-12-31 | CN¥1.84 Billion ≈ $268.73 Million |
CN¥57.83 Million ≈ $8.46 Million |
0.031x | -85.77% |
| 2020-12-31 | CN¥527.81 Million ≈ $77.24 Million |
CN¥116.79 Million ≈ $17.09 Million |
0.221x | +54.98% |
| 2019-12-31 | CN¥399.73 Million ≈ $58.49 Million |
CN¥57.07 Million ≈ $8.35 Million |
0.143x | -10.78% |
| 2018-12-31 | CN¥177.65 Million ≈ $26.00 Million |
CN¥28.43 Million ≈ $4.16 Million |
0.160x | +72.73% |
| 2017-12-31 | CN¥114.74 Million ≈ $16.79 Million |
CN¥10.63 Million ≈ $1.56 Million |
0.093x | +143.20% |
| 2016-12-31 | CN¥56.86 Million ≈ $8.32 Million |
CN¥-12.19 Million ≈ $-1.78 Million |
-0.214x | -484.77% |
| 2015-12-31 | CN¥32.65 Million ≈ $4.78 Million |
CN¥1.82 Million ≈ $266.30K |
0.056x | +146.55% |
| 2014-12-31 | CN¥33.10 Million ≈ $4.84 Million |
CN¥-3.96 Million ≈ $-579.94K |
-0.120x | -197.57% |
| 2013-12-31 | CN¥9.70 Million ≈ $1.42 Million |
CN¥1.19 Million ≈ $174.12K |
0.123x | -- |
About Shanghai Haoyuan Chemexpress Co. Ltd. A
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.